Gregor Diagnostics

About:

Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate cancer.

Website: http://www.gregordiagnostics.com

Top Investors: First Round Capital, gbeta, Health Wildcatters, Green Park & Golf Ventures

Description:

Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for and determining the aggressiveness of prostate cancer. The company was founded in 2016 and is headquartered in Madison, Wisconsin.

Total Funding Amount:

$6.89M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2016-01-01

Founders:

Tobias Zutz

Number of Employees:

11-50

Last Funding Date:

2021-10-27

IPO Status:

Private

Industries: